13F-HR filed by Alphabet Inc.
Alphabet Inc. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-05 23:21:46 UTC, with 29 holding rows worth $88,346,124,056.
- Accession
- 0001652044-26-000086
- Filer
- CIK 1652044
- Filed
- 2026-11-06
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 31 entries on the cover page, a total value of $88,346,124,056 stated on the cover page (in dollars after the unit check, H1), rows summing to $88,346,124,056 with VALUE read as dollars as filed, 13F file number 028-22702. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerGV Management Company, L.L.C.028-22704
- included managerGoogle LLC028-22705
- included managerCapitalG II LP028-22706
- included managerXXVI Holdings Inc.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP CLASS A COM STK | 84615Q103 | Stock | 555,043,560 | $83,733,871,462 | dollars as filed | |
| CME Group Inc. Class A | 12572Q105 | COM | 3,484,020 | $912,743,560 | dollars as filed | |
| PLANET LABS PBC | 72703X106 | COM CL A | 35,248,893 | $577,729,380 | dollars as filed | |
| ARM HOLDINGS PLC | 042068205 | SPONSORED ADS | 1,960,784 | $567,960,693 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,673,909 | $548,846,561 | dollars as filed | |
| Qualcomm Incorporated | 747525103 | COM | 2,976,982 | $547,883,767 | dollars as filed | |
| AST SPACEMOBILE INC COM CL A | 00217D100 | Stock | 8,943,486 | $526,413,586 | dollars as filed | |
| FRESHWORKS INC CLASS A COM | 358054104 | Stock | 14,336,643 | $183,365,664 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 4,919,498 | $158,850,590 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 1,551,102 | $127,035,254 | dollars as filed | |
| UIPATH INC | 90364P105 | CL A | 7,034,337 | $90,320,887 | dollars as filed | |
| Neutron Holdings Inc | 64125S104 | Common / Ordinary Stock | 1,898,948 | $53,493,365 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 16,562,498 | $50,681,244 | dollars as filed | |
| PAYPAY CORP | 70450C101 | SPONSORED ADS | 3,125,000 | $49,062,500 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,388,583 | $37,741,686 | dollars as filed | |
| FREENOME INC | 35661P100 | COMMON STOCK | 2,022,131 | $31,848,563 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,410,029 | $25,451,023 | dollars as filed | |
| FERVO ENERGY CO CL A COM | 31556C106 | Stock | 1,760,732 | $23,928,354 | dollars as filed | |
| ETHOS TECHNOLOGIES INC | 29765A101 | CL A | 571,907 | $19,198,918 | dollars as filed | |
| Obsidian Therapeutics, Inc. | 67448A106 | Common Stock, $0.0001 par value per share | 1,224,869 | $16,817,451 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 481,988 | $14,864,510 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 2,823,126 | $11,574,817 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 2,812,500 | $8,212,500 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 321,604 | $7,863,218 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 241,264 | $7,790,415 | dollars as filed | |
| FIGMA INC CL A | 316841105 | COM | 215,582 | $4,531,534 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 372,474 | $4,443,615 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 293,256 | $2,870,976 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 898,720 | $727,963 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001652044-26-000086 | this filing | 2026-11-06 |